Works matching IS 25739832 AND DT 2019 AND VI 1 AND IP 9
Results: 6
Issue Information.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 521, doi. 10.1096/fba.1086
- Publication type:
- Article
Aspirin ameliorates the long‐term adverse effects of doxorubicin through suppression of cellular senescence.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 579, doi. 10.1096/fba.2019-00041
- By:
- Publication type:
- Article
Cyclosporine A inhibits MRTF‐SRF signaling through Na<sup>+</sup>/K<sup>+</sup> ATPase inhibition and actin remodeling.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 561, doi. 10.1096/fba.2019-00027
- By:
- Publication type:
- Article
Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 550, doi. 10.1096/fba.2019-00040
- By:
- Publication type:
- Article
Kinetics of immune cell responses in the multiple low‐dose streptozotocin mouse model of type 1 diabetes.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 538, doi. 10.1096/fba.2019-00031
- By:
- Publication type:
- Article
Histone chaperone HIRA dictate proliferation vs differentiation of chronic myeloid leukemia cells.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 9, p. 525, doi. 10.1096/fba.2019-00014
- By:
- Publication type:
- Article